| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/28/2001 | US6280734 Simian-human HAV having a chimeric 2C protein |
| 08/28/2001 | US6280732 Administering intracerebrally al-1 immunoadhesin comprising mature al-1 polypeptide having specified amino acid sequence in amount effective to activate autophosphorylation of rek7 |
| 08/28/2001 | US6280731 Monoclonal antibody which binds to human von willebrand factor, inhibits ristocetin-dependent and botrocetin-dependent binding of human von willebrand factor to human platelets, exhibits antithrombotic action in guinea pigs |
| 08/28/2001 | US6280718 Hematopoietic differentiation of human pluripotent embryonic stem cells |
| 08/28/2001 | CA2333930A1 Dna sequence encoding the specific and antigenic outer membrane protein of s amonella typhi |
| 08/28/2001 | CA2203443C Hepatitis c virus asialoglycoproteins |
| 08/28/2001 | CA2178487C Local delivery of fibrinolysis enhancing agents |
| 08/28/2001 | CA2111845C Monoclonal antibodies specific for marrow-derived mesenchymal cells |
| 08/28/2001 | CA1341287C Polypeptides derived from human papillomavirus, antibodies to said polypeptide and detection of human papillomavirus latent proteins |
| 08/24/2001 | CA2338138A1 A method for production of a transgenic animal, and a transgenic animal produced by the method |
| 08/23/2001 | WO2001061356A1 Her-2 binding antagonists |
| 08/23/2001 | WO2001061346A2 Methods for identifying agents causing a lethal phenotype |
| 08/23/2001 | WO2001061020A2 Alteration of growth and adaptation under hypoxic conditions |
| 08/23/2001 | WO2001061013A1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 08/23/2001 | WO2001061010A2 Gtpase activating proteins |
| 08/23/2001 | WO2001061009A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001061006A2 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same |
| 08/23/2001 | WO2001061000A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof |
| 08/23/2001 | WO2001060992A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | WO2001060991A2 Human kinases |
| 08/23/2001 | WO2001060984A1 Immortalized vascular adventitial cell line |
| 08/23/2001 | WO2001060983A2 Treatment for bone disorders |
| 08/23/2001 | WO2001060982A1 Genetically engineered skin cell types and toxicity assays |
| 08/23/2001 | WO2001060981A1 Tooth progenitor cell and method for its production |
| 08/23/2001 | WO2001060979A1 Pancreatic islet cell growth factors |
| 08/23/2001 | WO2001060978A2 In ovo activation of an avian egg in the shell |
| 08/23/2001 | WO2001060975A2 Gene disruption methodologies in fungi for drug target discovery |
| 08/23/2001 | WO2001060857A2 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | WO2001060856A2 Vmglom gene and its mutations causing disorders with a vascular component |
| 08/23/2001 | WO2001060853A1 Transgenic animal model for obesity expressing foxc2 |
| 08/23/2001 | WO2001060850A1 Novel compounds |
| 08/23/2001 | WO2001060844A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | WO2001060838A2 Aids ancestral viruses and vaccines |
| 08/23/2001 | WO2001060397A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | WO2001025422A3 Antisense compositions and cancer-treatment methods |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001011031A3 Gene transfer to pancreatic beta cells for prevention of islet dysfunction |
| 08/23/2001 | WO2001009341A3 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase |
| 08/23/2001 | WO2001009298A3 Strategy for carbohydrate-based cancer vaccines |
| 08/23/2001 | WO2001007637A3 Conditionally controlled, attenuated HIV vaccine |
| 08/23/2001 | WO2001007611A3 Novel polynucleotides and method for the use thereof |
| 08/23/2001 | WO2001002030A3 Scaffold matrix and tissue maintaining systems |
| 08/23/2001 | WO2000078954A3 Human transcriptional regulator proteins |
| 08/23/2001 | WO2000055325A3 Plant centromeres |
| 08/23/2001 | WO1999047639A3 Staphylococcus aureus genes and polypeptides |
| 08/23/2001 | US20010016956 Introducing a DNA molecule into the plant cells whose growth is sensitive to inhibition by herbicides to which the protoporphyrinogen oxidase enzyme(protox) encoded by the DNA molecule is resistant, thus forming transformed plant cell |
| 08/23/2001 | US20010016953 Expression of sucrose phosphorylase on plants |
| 08/23/2001 | US20010016649 Nucleic acids and polypeptides; for diagnosing chondrosarcoma and for drug screening |
| 08/23/2001 | US20010016647 29 human secreted proteins |
| 08/23/2001 | US20010016353 Relic process for producing resorbable ceramic scaffolds |
| 08/23/2001 | US20010016348 Immortal avian cells |
| 08/23/2001 | US20010016347 Packaging cell |
| 08/23/2001 | US20010016345 Apoptotic protease Mch6, nucleic acids encoding same and methods of use |
| 08/23/2001 | US20010016340 Antihemophilia agent |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | US20010016332 Genetic engineering |
| 08/23/2001 | US20010016331 Serine protease specific monoclonal antibodies and their use |
| 08/23/2001 | US20010016324 Enzymatic splitting |
| 08/23/2001 | US20010016319 Cloning of a novel G-protein coupled 7TM Receptor |
| 08/23/2001 | US20010016199 Alphavirus RNA replicon systems |
| 08/23/2001 | DE10006822A1 Künstliche Knochenchips, Verfahren zu ihrer Herstellung und ihre Verwendung Artificial bone chips, processes for their preparation and their use |
| 08/23/2001 | DE10006033A1 New pharmaceutical for immunization against a carcinoma and its preliminary stages contains a cell cycle regulatory protein, particularly the cyclin-dependent kinase inhibitor p16 |
| 08/23/2001 | DE10004468A1 Allenoxidcyclasegen und dessen Verwendung zum Herstellen von Jasmonsäure Allenoxidcyclasegen and its use for the production of jasmonic acid |
| 08/23/2001 | CA2402440A1 Aids ancestral viruses and vaccines |
| 08/23/2001 | CA2400706A1 Genetically engineered skin cell types and toxicity assays |
| 08/23/2001 | CA2400607A1 Tooth progenitor cell and method for its production |
| 08/23/2001 | CA2400588A1 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | CA2400473A1 Her-2 binding antagonists |
| 08/23/2001 | CA2400360A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400355A1 Pancreatic islet cell growth factors |
| 08/23/2001 | CA2400342A1 Transgenic animal model for obesity expressing foxc2 |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400328A1 Methods for identifying agents that cause a lethal phenotype, and agents thereof |
| 08/23/2001 | CA2400256A1 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | CA2400101A1 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | CA2400034A1 Human kinases |
| 08/23/2001 | CA2399705A1 Treatment for bone disorders |
| 08/23/2001 | CA2399137A1 Alteration of growth and adaptation under hypoxic conditions |
| 08/23/2001 | CA2398861A1 Gene disruption methodologies for drug target discovery |
| 08/23/2001 | CA2398825A1 Gtpase activating proteins |
| 08/23/2001 | CA2398628A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, andantagonists thereof |
| 08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | CA2396793A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | CA2337574A1 Hematopoietic stem cell expansion enhancing factor and method of use |
| 08/22/2001 | EP1126028A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 08/22/2001 | EP1126027A1 Cell death inhibition by the caspase-12 activation inhibitor MAGE-3 |
| 08/22/2001 | EP1126022A2 Method of preserving white blood cells with CLA |
| 08/22/2001 | EP1125947A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 08/22/2001 | EP1124989A1 Method for determining cancer by determining expression of mage-10 |
| 08/22/2001 | EP1124984A1 Host cells expressing recombinant human erythropoietin |
| 08/22/2001 | EP1124977A1 Modified adenoviral fibre and uses thereof |
| 08/22/2001 | EP1124976A1 Improved aav vector production |
| 08/22/2001 | EP1124974A2 Hypersensitive response elicitor-induced stress resistance |
| 08/22/2001 | EP1124971A1 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use |
| 08/22/2001 | EP1124970A1 Process of purification of low density lipoprotein associated phospholipase a2 using immobilized metal affinity chromatography |
| 08/22/2001 | EP1124967A1 PLANT-OPTIMIZED POLYNUCLEOTIDES ENCODING APPROXIMATELY 15 kDa AND APPROXIMATELY 45 kDa PESTICIDAL PROTEINS |
| 08/22/2001 | EP1124966A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |